WiseGuyReports.Com Publish a New Market Research Report On - “Endocrinology Drugs: Global Market Sales, Consumption, Demand and Forecast 2017 – 2020”.

New York, NY -- (SBWire) -- 08/07/2017 --The analysts forecast the global endocrinology drugs market to grow at a CAGR of 6.69% during the period 2016-2020.

Endocrinology deals with the study of the endocrine system, including the biochemical and physiological functions of the hormones, cells, and tissues of the endocrine glands. Endocrine disorders can be broadly subdivided into three categories: endocrine gland hyposecretion, which causes hormone deficiency, endocrine gland hypersecretion, which causes excess hormone secretion, and tumors in the endocrine gland. The endocrine disorders considered for the present report include diabetes, human growth hormone deficiency, thyroid disorders, and male hypogonadism.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/417270-global-endocrinology-drugs-market-2016-2020

For more information or any query mail at sales@wiseguyreports.com

Covered in this report

The report covers the present scenario and the growth prospects of the global endocrinology drugs market for 2015-2020. To calculate the market size, the report considers revenue generated from the sales of branded drugs, generics, and biosimilars used to treat and prevent type 1 and type 2 diabetes, human growth hormone deficiency, hypogonadism, and thyroid gland disorders.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Endocrinology Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- AbbVie Inc.
- AstraZeneca PLC
- Eli Lilly and Co.
- Merck & Co
- Novo Nordisk AS
- Sanofi SA

Other prominent vendors
- Acerus Pharmaceuticals
- Acrux DDS
- Adocia
- Æterna Zentaris
- Akros Pharma
- Allergan
- Amgen
- Antares Pharma
- Ascendis Pharma
- Astellas Pharma
- Baxalta
- Bayer HealthCare Pharmaceuticals
- BHV Pharma
- Biocon
- Biodel
- Boehringer Ingelheim
- ChipScreen Biosciences
- Clarus Therapeutics
- ConjuChem
- Critical Pharmaceuticals
- CureDm
- CymaBay Therapeutics
- Daiichi Sankyo
- Dance Biopharm
- DiaMedica
- Diamyd Therapeutics
- Diasome Pharmaceuticals
- DiaVacs
- Dong-A ST
- Eisai
- Elcelyx Therapeutics
- Endo Pharmaceuticals
- Exsulin
- Ferring Pharmaceuticals
- Gan & Lee Pharmaceuticals
- Genentech
- Generex
- Genexine
- Genfit
- GSK
- HanAll BioPharma
- Hanmi Pharmaceutical
- Hua Medicine
- ILTOO Pharma
- Intarcia Therapeutics
- InteKrin Therapeutics
- Intrexon
- Ionis Pharmaceuticals
- Ipe
- Islet Sciences
- Janssen Pharmaceuticals
- Japan Tobacco
- Juniper Pharmaceuticals
- Kadmon Corporation
- Kamada
- KinDex Pharmaceuticals
- Kissei Pharmaceutical
- Kotobuki
- Lexicon Pharmaceuticals
- LG Life Sciences
- Ligand Pharmaceuticals
- Lipocine
- Living Cell Technologies
- MacroGenics
- MannKind
- MedImmune
- Melior Pharmaceuticals
- Metabolic Solutions Development Company
- MetP Pharma
- Mitsubishi Tanabe Pharma
- Mylan
- NGM Biopharmaceuticals
- Novartis
- NuSirt Biopharma
- OPKO Biologics
- Oramed Pharmaceuticals
- Osiris Therapeutics
- Peptron
- Perle Biosciences
- Pfizer
- PhaseBio Pharmaceuticals
- Poxel
- ProStrakan Group
- REGiMMUNE
- Repros Therapeutics
- Roche
- Sanwa Kagaku Kenkyusho
- Sirona Biochem
- Strongbridge Biopharma
- Takeda Pharmaceuticals
- TesoRx Pharma
- Teva Pharmaceutical
- Theracos
- Theratechnologies
- Toleranzia
- Tolerion
- Transition Therapeutics
- VeroScience
- Versartis
- vTv Therapeutics
- XBiotech
- Xeris Pharmaceuticals
- XOMA

Market driver
- Increase in prevalence of endocrine hormone-related diseases
- For a full, detailed list, view our report

Market challenge
- Generic erosion
- For a full, detailed list, view our report

Market trend
- Increase in outsourcing
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Report Details @ https://www.wiseguyreports.com/reports/417270-global-endocrinology-drugs-market-2016-2020

Table Of Contents – Major Key Points

PART 01: Executive summary
- Highlights

PART 02: Scope of the report
- Market overview
- Top-vendor offerings

PART 03: Market research methodology
- Research methodology
- Economic indicators

PART 04: Introduction
- Key market highlights

PART 05: Key buying criteria

PART 06: Pipeline portfolio

PART 07: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis

PART 08: Market segmentation by application

PART 09: Global diabetes drugs market
- Introduction
- Market overview
- Market drivers
- Market challenges
- Market trends
- Vendor analysis of global diabetes drugs market

Continued…..

For more information or any query mail at sales@wiseguyreports.com

Buy 1-User PDF@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=417270

About Wise Guy Reports
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.